The world's leading researchers in allergic disease will gather in San Antonio, March 18-22, 2005, for the American Academy of Allergy, Asthma and Immunology's (AAAAI's) 2005 Annual Meeting. The AAAAI Annual Meeting is the largest gathering of allergists/immunologists, allied health professionals and researchers from around the world.
Educational sessions will explore:
- Hot topics in allergy and asthma
- Advances in peanut allergy
- Treatment of asthma in early childhood
- Allergic reactions to vaccines
- Hygiene Hypothesis for asthma
- Allergic asthma therapy
- Overcoming inhaled steroid phobia
- The role of IgE in allergic disease
In addition, this year's meeting has several new features, including:
Keynote speaker Leroy Hood, MD, one of the world's leading scientists in molecular biotechnology and genomics, will present a keynote session on Saturday, March 19. With his development of the DNA gene sequencer and other automated biotechnical instrumentation, Dr. Hood has played a crucial role in contributing to the successful mapping of the human genome during the 1990s, a process originally predicted to require up to 100 years to complete.
More Plenary Sessions - There will be six plenary sessions at the 2005 Annual Meeting, one each on Saturday and Sunday, and two each on Monday and Tuesday. Plenary sessions are the premier educational sessions of the meeting. Topics discussed include: Management of childhood asthma, advances in peanut allergy, and curative vaccines for allergy.
NEW Pro/Con Debates
Twelve one-hour sessions in which two presenters provide opposing views on a controversial topic. Topics debated include sublingual immunotherapy, anti-IgE therapy for food allergy, chronic sinusitis: role of fungi
For a complete schedule of educational sessions, visit the 2005 AAAAI Annual Meeting section of the AAAAI Web site,
Contact: John Gardner
jgardner@aaaai.org
414-272-6071
American Academy of Allergy, Asthma & Immunology
12-Jan-2005
Page: 1 2 Related medicine news :1.
Leading tobacco manufacturer conceals links to tobacco research facility2.
Leading MRSA experts address emergence of superbug3.
Leading causes of blindness for blacks and whites different4.
Leading cancer doctor calls for new guidelines to control early reporting from clinical trials5.
Leading AIDS experts criticize US-sponsored HIV vaccine trial in Thailand6.
Leading the way in novel anti-cancer research7.
Leading American, German chemists converge to share research, vision8.
Leading anti-cancer factions strengthen bonds9.
Leading NIH-funded medical schools agree on guidelines that would strenghten conflict of interest policies10.
Biochemical Marker Targets Brain Injury Leading To Movement Problems After Stroke11.
New Model Shows How To Eradicate Worlds Leading Infectious Cause Of Blindness